InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Dube Michael P. Director active across 1 company, notably Intellia Therapeutics, Inc.. Cumulatively, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €51k. Activity tracked since 1 July 2024. The latest transaction was filed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations